Publication: Alginate Carboxymethylcellulose Hyaluronic Acid for Preventing Intrauterine Adhesion after Vacuum Aspiration for First-Trimester Abortion: A Prospective, Randomized Controlled Trial
Issued Date
2021-10-01
Resource Type
ISSN
15577724
10424067
10424067
Other identifier(s)
2-s2.0-85117685409
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of Gynecologic Surgery. Vol.37, No.5 (2021), 402-407
Suggested Citation
Jidapa Vatanatara, Yada Tingthanatikul, Srithean Lertvikool, Woradej Hongsakorn Alginate Carboxymethylcellulose Hyaluronic Acid for Preventing Intrauterine Adhesion after Vacuum Aspiration for First-Trimester Abortion: A Prospective, Randomized Controlled Trial. Journal of Gynecologic Surgery. Vol.37, No.5 (2021), 402-407. doi:10.1089/gyn.2020.0196 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/77794
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Alginate Carboxymethylcellulose Hyaluronic Acid for Preventing Intrauterine Adhesion after Vacuum Aspiration for First-Trimester Abortion: A Prospective, Randomized Controlled Trial
Other Contributor(s)
Abstract
Objectives: This trial examined the effectiveness of intrauterine alginate carboxymethylcellulose hyaluronic acid-(ACH) gel application after vacuum aspiration as a treatment in first-trimester abortion to reduce formation and severity of intrauterine adhesions (IUAs). Materials and Methods: This prospective, single-blinded, randomized controlled trial included 68 pregnant women, at a gestational age of ≤13 weeks, who were diagnosed with abortion without previous histories of curettage, and who underwent termination of pregnancy by vacuum aspiration. After vacuum aspiration, the participants were assigned randomly to an intervention group (with ACH-gel application; n = 34) or a control group (no ACH gel application; n = 34). All participants were scheduled for office hysteroscopy 8-12 weeks after vacuum aspiration to evaluate the IUAs. Results: Six participants did not undergo hysteroscopy. Therefore, outcomes were available for only 62 patients - 32 in the intervention group and 30 in the control group. IUAs were noted in 17 patients (27.42%), with 5 participants (8.06%) in the intervention group and 12 participants (19.35%) in the control group (relative risk = 0.39; 95% confidence interval: 0.16-0.98; p = 0.04). The severity of IUAs was not significantly different between both groups (p = 0.61). Conclusions: The application of ACH gel after vacuum aspiration in patients who have miscarriages without previous histories of curettage can reduce IUA formation significantly.